Article
2'-Hydroxyflavanone: A promising molecule for kidney cancer prevention.
Biochemical pharmacology - 1 Aug 2015
Singhal Sharad S, Singhal Jyotsana, Figarola James L, Riggs Arthur, Horne David, Awasthi Sanjay
Abstract excerpt
Kidney cancer, also known as renal cell carcinoma (RCC), is one of the top 10 diagnosed cancers in the USA, and the incidence is rising. Despite major improvements in drug therapy strategies, RCC remains a deadly malignancy if not found and removed in its early stages. RCC is so highly drug-resistant that no effective life-prolonging regimen of cytotoxic chemotherapy has been demonstrated for RCC, despite several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
